| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 43.38% | DA Davidson | $50 → $55 | Upgrades | Neutral → Buy |
| 11/03/2023 | 30.34% | Goldman Sachs | $58 → $50 | Maintains | Buy |
| 10/24/2023 | 25.13% | Citigroup | $56 → $48 | Maintains | Neutral |
| 10/12/2023 | -8.76% | Barclays | $41 → $35 | Maintains | Underweight |
| 08/07/2023 | 43.38% | Truist Securities | $50 → $55 | Maintains | Buy |
| 08/07/2023 | 6.88% | Barclays | $35 → $41 | Maintains | Underweight |
| 08/04/2023 | 22.52% | Morgan Stanley | $43 → $47 | Maintains | Equal-Weight |
| 08/04/2023 | 51.2% | Goldman Sachs | $52 → $58 | Maintains | Buy |
| 07/21/2023 | 64.23% | Keybanc | $50 → $63 | Maintains | Overweight |
| 07/19/2023 | -8.76% | Barclays | $30 → $35 | Maintains | Underweight |
| 06/22/2023 | 48.59% | Citigroup | $40 → $57 | Maintains | Neutral |
| 06/06/2023 | 4.28% | DA Davidson | → $40 | Initiates Coverage On | → Neutral |
| 02/17/2023 | 19.92% | Morgan Stanley | $42 → $46 | Maintains | Equal-Weight |
| 02/17/2023 | 30.34% | Truist Securities | $45 → $50 | Maintains | Buy |
| 02/17/2023 | 43.38% | Keybanc | $46 → $55 | Maintains | Overweight |
| 01/20/2023 | 17.31% | Truist Securities | $50 → $45 | Maintains | Buy |
| 01/18/2023 | 19.92% | Keybanc | $55 → $46 | Maintains | Overweight |
| 01/10/2023 | -34.83% | Barclays | $30 → $25 | Maintains | Underweight |
| 12/21/2022 | -3.55% | SMBC Nikko | → $37 | Initiates Coverage On | → Neutral |
| 11/07/2022 | 30.34% | Truist Securities | $65 → $50 | Maintains | Buy |
| 11/07/2022 | 43.38% | Goldman Sachs | $71 → $55 | Maintains | Buy |
| 11/04/2022 | 9.49% | Morgan Stanley | $54 → $42 | Maintains | Equal-Weight |
| 10/20/2022 | 40.77% | Morgan Stanley | $60 → $54 | Maintains | Equal-Weight |
| 10/18/2022 | -16.58% | Barclays | $37 → $32 | Maintains | Underweight |
| 09/13/2022 | 56.41% | Keybanc | → $60 | Initiates Coverage On | → Overweight |
| 09/01/2022 | 43.38% | Citigroup | → $55 | Initiates Coverage On | → Neutral |
| 05/11/2022 | 100.73% | Goldman Sachs | $65 → $77 | Maintains | Buy |
| 04/27/2022 | 82.48% | Goldman Sachs | → $70 | Initiates Coverage On | → Buy |
| 04/19/2022 | 9.49% | Barclays | $47 → $42 | Maintains | Underweight |
| 01/25/2022 | 43.38% | Morgan Stanley | $87 → $55 | Maintains | Equal-Weight |
| 01/12/2022 | 22.52% | Barclays | $90 → $47 | Maintains | Underweight |
| 12/17/2021 | 160.69% | Truist Securities | $116 → $100 | Maintains | Buy |
| 12/03/2021 | 126.8% | Morgan Stanley | $95 → $87 | Upgrades | Underweight → Equal-Weight |
| 11/08/2021 | 202.4% | Truist Securities | $105 → $116 | Upgrades | Hold → Buy |
| 11/05/2021 | 343.17% | Needham | $186 → $170 | Maintains | Buy |
| 09/17/2021 | 134.62% | Barclays | $77 → $90 | Maintains | Underweight |
| 08/06/2021 | 384.88% | Needham | $190 → $186 | Maintains | Buy |
| 08/02/2021 | 212.83% | Truist Securities | $205 → $120 | Maintains | Hold |
| 05/25/2021 | 108.55% | Macquarie | → $80 | Upgrades | Underperform → Neutral |
| 05/07/2021 | 137.23% | Morgan Stanley | $100 → $91 | Maintains | Underweight |
| 05/07/2021 | 395.31% | Needham | $235 → $190 | Maintains | Buy |
| 02/19/2021 | 369.24% | Goldman Sachs | $84 → $180 | Maintains | Neutral |
| 02/19/2021 | 116.37% | Barclays | $76 → $83 | Maintains | Underweight |
| 02/19/2021 | 512.62% | Needham | $193 → $235 | Maintains | Buy |
| 01/22/2021 | 160.69% | Morgan Stanley | $80 → $100 | Maintains | Underweight |
| 01/19/2021 | 403.13% | Needham | $94 → $193 | Maintains | Buy |
| 12/01/2020 | — | Barclays | Downgrades | Equal-Weight → Underweight | |
| 11/09/2020 | 118.98% | Goldman Sachs | → $84 | Upgrades | Sell → Neutral |
| 11/06/2020 | 6.88% | Morgan Stanley | $38 → $41 | Maintains | Underweight |
| 11/06/2020 | 145.05% | Needham | → $94 | Upgrades | Hold → Buy |
| 10/09/2020 | 79.87% | Barclays | $48 → $69 | Maintains | Equal-Weight |
| 08/17/2020 | -0.94% | Morgan Stanley | $35 → $38 | Maintains | Underweight |
| 07/21/2020 | 48.59% | Berenberg | → $57 | Initiates Coverage On | → Buy |
| 05/11/2020 | -8.76% | Morgan Stanley | $32 → $35 | Maintains | Underweight |
| 04/14/2020 | -16.58% | Morgan Stanley | → $32 | Downgrades | Equal-Weight → Underweight |
| 02/24/2020 | 4.28% | Canaccord Genuity | $44 → $40 | Maintains | Hold |
| 02/21/2020 | 25.13% | Cowen & Co. | $42 → $48 | Maintains | Market Perform |
| 02/19/2020 | — | Needham | Downgrades | Buy → Hold | |
| 01/10/2020 | 27.74% | Needham | → $49 | Initiates Coverage On | → Buy |
| 08/09/2019 | 19.92% | SunTrust Robinson Humphrey | $32 → $46 | Maintains | Hold |
| 05/23/2019 | -6.15% | Morgan Stanley | $30 → $36 | Upgrades | Underweight → Equal-Weight |
| 05/16/2019 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 02/01/2019 | — | Goldman Sachs | Reinstates | → Sell |
What is the target price for Appian (APPN)?
The latest price target for Appian (NASDAQ: APPN) was reported by DA Davidson on November 7, 2023. The analyst firm set a price target for $55.00 expecting APPN to rise to within 12 months (a possible 43.38% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Appian (APPN)?
The latest analyst rating for Appian (NASDAQ: APPN) was provided by DA Davidson, and Appian upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Appian (APPN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Appian, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Appian was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Appian (APPN) correct?
While ratings are subjective and will change, the latest Appian (APPN) rating was a upgraded with a price target of $50.00 to $55.00. The current price Appian (APPN) is trading at is $38.36, which is out of the analyst's predicted range.